Neuro-Oncology

Published by: Oxford University Press  

People

  1. Grommes
    Grommes
  2. Pentsova
    Pentsova
  3. Gavrilovic
    Gavrilovic
  4. Kaley
    Kaley
  5. Mellinghoff
    Mellinghoff
  6. Schaff
    Schaff
  7. Nolan
    Nolan
  8. Lin
    Lin
  9. Young
    Young
  10. Stone
    Stone

Groups

  1. Tow Center for Developmental Oncology (TCDO) (19)
  2. GSK Faculty (15)
  3. Radiology, Department of (15)
  4. Human Oncology and Pathogenesis Program (14)
  5. Neuroradiology Service (14)
  6. Department of Medicine (10)
  7. Epidemiology and Biostatistics (8)
  8. Graduate Medical Education (8)
  9. Biostatistics Service (7)
  10. Radiation Oncology, Department of (7)
Search Within
  1. "Christian Grommes"
Formats
  1. Meeting Abstract (30)
  2. Journal Article (5)
  3. Review (3)
  4. Guidelines (1)
Groups
  1. Tow Center for Developmental Oncology (TCDO) (19)
  2. GSK Faculty (15)
  3. Radiology, Department of (15)
  4. Human Oncology and Pathogenesis Program (14)
  5. Neuroradiology Service (14)
  6. Department of Medicine (10)

More Groups

People
  1. Christian Grommes (39)
  2. Lisa De Angelis (16)
  3. Elena Pentsova (15)
  4. Igor Gavrilovic (13)
  5. Ingo Mellinghoff (12)
  6. Lauren Schaff (12)

More People

Years
  1. 2025 (1)
  2. 2024 (5)
  3. 2023 (1)
  4. 2022 (4)
  5. 2021 (4)
  6. 2020 (4)

More Years

Publishers
  1. Oxford University Press (39)

Results (39)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Phase Ib study with expansion of ibrutinib, lenalidomide, and rituximab in patients with relapsed/refractory central nervous system lymphoma
    Journal Article

    Schaff, L. R.; Piotrowski, A. F.; Pentsova, E.; Gavrilovic, I. T.; Lin, A.; Kaley, T. J.; Wongchai, V.; Emadi-Paramkouhi, L.; Madzsar, J.; Quinn, L.; more...
    Neuro-Oncology (2025)

    Fulltext@MSK | Save
  • Central nervous system bridging radiotherapy (CNS-BRT) achieves rapid cytoreduction prior to car T-cell therapy for aggressive B-cell lymphomas
    Meeting Abstract

    Cederquist, G.; Schefflein, J.; Devlin, S.; Shah, G.; Shouval, R.; Hubbeling, H.; Tringale, K.; Fregonese, B.; Hajj, C.; Boardman, A.; more...
    Neuro-Oncology (2024)

    Fulltext@MSK | Save
  • Patterns of intracranial response and relapse after CNS-directed radiotherapy (CNS-RT) for patients with chemorefractory or progressive secondary CNS lymphoma (SCNSL)
    Meeting Abstract

    Cederquist, G.; Tringale, K.; Hajj, C.; Moore, Z.; Hubbeling, H.; Dreyfuss, A.; Fregonese, B.; Falchi, L.; Scordo, M.; Grommes, C.; more...
    Neuro-Oncology (2024)

    Fulltext@MSK | Save
  • Prospective germline sequencing of patients with gliomas, glioneuronal or neuronal tumors
    Meeting Abstract

    Lin, A.; Nandakumar, S.; Mehine, M.; Kemel, Y.; Mandelker, D.; Karajannis, M.; Sait, S. F.; Gavrilovic, I.; Pentsova, E.; Schaff, L.; more...
    Neuro-Oncology (2024)

    Fulltext@MSK | Save
  • Outcomes and relapse patterns in primary central nervous system lymphoma: Longitudinal analysis of 559 patients diagnosed from 1983 to 2020
    Journal Article

    Tringale, K. R.; Scordo, M.; Yahalom, J.; White, C.; Zhang, Z.; Vachha, B.; Cederquist, G.; Schaff, L.; Deangelis, L.; Grommes, C.; more...
    Neuro-Oncology (2024)

    Fulltext@MSK | Save
  • Liquid biopsy for improving diagnosis and monitoring of CNS lymphomas: A RANO review
    Review

    Nayak, L.; Bettegowda, C.; Scherer, F.; Galldiks, N.; Ahluwalia, M.; Baraniskin, A.; von Baumgarten, L.; Bromberg, J. E. C.; Ferreri, A. J. M.; Grommes, C.; more...
    Neuro-Oncology (2024)

    Fulltext@MSK | Save
  • Results of safety lead in of phase IL trial of combination olaparib, temozolomide, and pembrolizumab for patients with IDH-mutant glioma
    Meeting Abstract

    Fortunato, J.; Newton, A.; Gonzalez, A.; Gavrilovic, I.; Miller, A.; Grommes, C.; Lin, A.; Pentsova, E.; Mellinghoff, I.; Kaley, T.; more...
    Neuro-Oncology (2023)

    Fulltext@MSK | Save
  • Non-invasive diagnosis of IDH-mutant brainstem gliomas
    Meeting Abstract

    Kushnirsky, M.; Thakur, S.; Karajannis, M.; Bale, T.; Rosenblum, M.; Malani, R.; Gavrilovic, I. T.; Schaff, L.; Pentsova, E.; Grommes, C.; more...
    Neuro-Oncology (2022)

    Fulltext@MSK | Save
  • Neurotoxicity after a single cycle of intravenous cytarabine
    Meeting Abstract

    Herbst, J.; Grommes, C.; Schaff, L.
    Neuro-Oncology (2022)

    Fulltext@MSK | Save
  • Identifying patterns of failure after initial therapy in primary CNS lymphoma in a large patient cohort
    Meeting Abstract

    Tringale, K.; Yahalom, J.; Scordo, M.; Vachha, B.; Schaff, L.; Grommes, C.; Imber, B.
    Neuro-Oncology (2022)

    Fulltext@MSK | Save

    • Neuro-Oncology – authorized name for:

    Name ISSN / ISBN Publisher
    Neuro-Oncology 1523-5866 Oxford University Press
    Neuro-Oncology 1522-8517 Oxford University Press
    Neuro-Oncology 1523-5866 Oxford University Press
    Neuro-Oncology 1522-8517 Oxford University Press
    Neuro-Oncology 1522-8517 Oxford University Press
    Neuro-Oncology 1523-5866 Oxford University Press
    Neuro-oncology 1523-5866 Oxford University Press
    Neuro-Oncology 1523-5866 Oxford University Press
    Neuro-Oncology 1522-8517 Oxford University Press On Behalf of the Society for Neuro Oncology
    Neuro-Oncology 1523-5866 Oxford University Press
    Neuro-Oncology 1522-8517 Oxford University Press
    Neuro-Oncology 1522-8517 Oxford University Press
    Neuro-Oncology 1522-8517 Oxford University Press
    Neuro-Oncology 1522-8517 Oxford University Press
    Neuro-Oncology 1523-5866 Oxford University Press
    Neuro-oncology 15235866 Unknown
    Neuro-Oncology 15228517 The Author(s) 2024
    Neuro-Oncology 1523-5866 Oxford University Press
    Neuro-Oncology 1522-8517 Oxford University Press
    Neuro-Oncology 15228517 The Author(s)
    Neuro-Oncology 1522-8517 Oxford University Press
    Neuro-Oncology 15228517 Oxford University Press On Behalf of the Society for Neuro Oncology
    Neuro-Oncology 1522-8517 Carden Jennings Publ Co Ltd
    Neuro-Oncology 1522-8517 Duke University Press
    Neuro-Oncology 1522-8517 Oxford University Press
    Neuro-Oncology 15228517 Unknown
    Neuro-Oncology 1522-8517 Oxford University Press
    Neuro-Oncology 15228517 The Author(s) 2023
    Neuro-Oncology 1522-8517 Oxford University Press
    Neuro-oncology 1523-5866 Oxford University Press
    Neuro-Oncology 1522-8517 Oxford University Press
    Neuro-Oncology 1522-8517 Oxford University Press
    Neuro-Oncology 1522-8517 Oxford University Press
    Neuro-Oncology 1522-8517 Oxford University Press
    Neuro-Oncology 1523-5866 Oxford University Press
    Neuro-Oncology 1523-5866 Oxford University Press
    Neuro-oncology 15235866 Oxford University Press On Behalf of the Society for Neuro Oncology
    Neuro-Oncology 1522-8517 Duke University Press
    Neuro-Oncology 1522-8517 Oxford University Press
    Neuro-Oncology 1523-5866 Oxford University Press On Behalf of the Society for Neuro Oncology
    Neuro-Oncology 1522-8517 Oxford University Press
    Neuro-Oncology 1522-8517 Oxford University Press
    Neuro-Oncology 1522-8517 Oxford University Press
    Neuro-Oncology 15235866 Elsevier B.V.
    Neuro-Oncology 1522-8517 Society for Neuro Oncology